Kathy Malas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kathy Malas has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Hassane Alami
Department of Health Management, Evaluation and Policy School of Public Health University of Montreal Montreal Quebec Canada
5 shared publications - Marie-Pascale Pomey
Research Centre of the University of Montreal Hospital Centre, Montreal, Canada
5 shared publications - Fabrice Brunet
Executive Office, Centre hospitalier de l’Université de Montréal, Montreal, Quebec, Canada
4 shared publications - Lysanne Rivard
Center for Public Health Research of the University of Montreal Montreal Quebec Canada
4 shared publications - Cécile Vialaron
Carrefour de l'Innovation, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada
3 shared publications - Jean-Paul Fortin
Faculty of Medicine, Laval University, Québec, QC, Canada
3 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 8 June 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28 (1) , e87448
Artificial Intelligence Governance in Health Systems: Systematic Review of Frameworks and Integrative Model Proposal
Background: Several artificial intelligence (AI) governance frameworks have emerged to help health systems (HS) address AI-related risks. However, most fail to capture the multidimensional and evolving nature of real-world governance. Objective: This systematic review aimed to synthesize existing AI governance frameworks for HS and to propose an integrative AI governance model identifying key components to guide AI-related policy, practice, and research in HS. Methods: A comprehensive search was conducted in 8 academic databases (PubMed, MEDLINE, Embase, ACM Digital Library, Web of Science, Scopus, Social Sciences Abstracts, and PsycINFO), gray literature databases, and international organization web portals in October 2024 (updates: July 2025 and March 2026) and limited to studies published from November 2014 to March 2026 in English, French, Spanish, or Portuguese. Eligible documents included peer-reviewed articles and reports proposing AI governance frameworks for HS. Two reviewers independently selected the frameworks, assessed their quality using the Appraisal of Guidelines for Research and Evaluation for Health Systems, and extracted data. Results were synthesized using thematic analysis. Results: The research retrieved 10,175 records, among which 19 AI governance frameworks were identified. Most were published between 2022 and 2024 (n=13, 68%), half (n=10, 53%) were developed by authors based in North America, and only one-third (n=6, 32%) were derived from primary studies. The frameworks focused on 4 levels of AI governance: international (n=3, 16%), national (n=5, 26%), local (n=3, 16%), and organizational (n=8, 42%). All of them underline the crucial role of multidisciplinary bodies in the structure of AI governance in HS. Six key AI governance processes in HS emerged as critical: (1) need and/or problem identification (n=14, 74%), (2) data governance (n=17, 89%), (3) risk assessment and management (n=17, 89%), (4) validation and/or evaluation (n=18, 95%), (5) maintenance and monitoring (n=16, 84%), and (6) integration (n=9, 47%). Additionally, 4 pivotal relational mechanisms were identified: (1) ethical principles and/or values (n=17, 89%), (2) education and training (n=14, 74%), (3) communication (n=12, 63%), and (4) standards and regulations (n=13, 68%). Conclusions: Our study provides a comprehensive synthesis of existing AI governance frameworks for HS across 4 levels (local, regional, national, and international), underpinned by a quality assessment of the 19 identified frameworks. It differs from existing studies that concentrate on specific dimensions or settings by contributing an integrative AI governance model for HS comprising 2 dimensions and 4 relational mechanisms across the 4 levels, explicitly modeling their interactions. Future research should test and operationalize the proposed model to enhance its practical applicability. Strengthening the methodological rigor of AI governance frameworks will be essential for the responsible integration of AI in HS. As the framework is primarily grounded in Global North and English-language literature, validation in other contexts is warranted.
- 8 June 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28 (1) , e87448
Top Cited PapersOpen AccessArtificial Intelligence Governance in Health Systems: Systematic Review of Frameworks and Integrative Model Proposal
Background: Several artificial intelligence (AI) governance frameworks have emerged to help health systems (HS) address AI-related risks. However, most fail to capture the multidimensional and evolving nature of real-world governance. Objective: This systematic review aimed to synthesize existing AI governance frameworks for HS and to propose an integrative AI governance model identifying key components to guide AI-related policy, practice, and research in HS. Methods: A comprehensive search was conducted in 8 academic databases (PubMed, MEDLINE, Embase, ACM Digital Library, Web of Science, Scopus, Social Sciences Abstracts, and PsycINFO), gray literature databases, and international organization web portals in October 2024 (updates: July 2025 and March 2026) and limited to studies published from November 2014 to March 2026 in English, French, Spanish, or Portuguese. Eligible documents included peer-reviewed articles and reports proposing AI governance frameworks for HS. Two reviewers independently selected the frameworks, assessed their quality using the Appraisal of Guidelines for Research and Evaluation for Health Systems, and extracted data. Results were synthesized using thematic analysis. Results: The research retrieved 10,175 records, among which 19 AI governance frameworks were identified. Most were published between 2022 and 2024 (n=13, 68%), half (n=10, 53%) were developed by authors based in North America, and only one-third (n=6, 32%) were derived from primary studies. The frameworks focused on 4 levels of AI governance: international (n=3, 16%), national (n=5, 26%), local (n=3, 16%), and organizational (n=8, 42%). All of them underline the crucial role of multidisciplinary bodies in the structure of AI governance in HS. Six key AI governance processes in HS emerged as critical: (1) need and/or problem identification (n=14, 74%), (2) data governance (n=17, 89%), (3) risk assessment and management (n=17, 89%), (4) validation and/or evaluation (n=18, 95%), (5) maintenance and monitoring (n=16, 84%), and (6) integration (n=9, 47%). Additionally, 4 pivotal relational mechanisms were identified: (1) ethical principles and/or values (n=17, 89%), (2) education and training (n=14, 74%), (3) communication (n=12, 63%), and (4) standards and regulations (n=13, 68%). Conclusions: Our study provides a comprehensive synthesis of existing AI governance frameworks for HS across 4 levels (local, regional, national, and international), underpinned by a quality assessment of the 19 identified frameworks. It differs from existing studies that concentrate on specific dimensions or settings by contributing an integrative AI governance model for HS comprising 2 dimensions and 4 relational mechanisms across the 4 levels, explicitly modeling their interactions. Future research should test and operationalize the proposed model to enhance its practical applicability. Strengthening the methodological rigor of AI governance frameworks will be essential for the responsible integration of AI in HS. As the framework is primarily grounded in Global North and English-language literature, validation in other contexts is warranted.
- Open Access
- 16 December 2025
- Published by Universite du Quebec a Chicoutimi in Revue Organisations & territoires
- Vol. 34 (3) , 188-193
Soutenir les micro-innovations comme moteur du changement en santé grâce à des approches participatives
Les systèmes de santé font face à des défis croissants qui nécessitent des innovations adaptées au terrain. En nous appuyant sur la place centrale des professionnels et des utilisateurs dans le Consolidated Framework for Implementation Research (CFIR; Breimaier et collab., 2015) pour instaurer et implanter le changement, nous mettons de l’avant le concept des micro-innovations. Ces initiatives locales peuvent transformer les pratiques organisationnelles. Nous présentons d’abord une micro-innovation locale qui a transformé les soins en fin de vie grâce à un protocole visant à protéger le patient et ses proches de la COVID-19 afin d’assurer du soutien émotionnel aux soins intensifs. Nous suggérons ensuite trois approches participatives pour faciliter l’émergence de micro-innovations : le design thinking, les hackathons et la cocréation avec les patients et proches-partenaires. Pour générer un réel impact, ces micro-innovations nécessitent un accompagnement organisationnel. En les valorisant, les systèmes de santé peuvent évoluer de manière plus agile, inclusive et durable.
- 16 December 2025
- Published by Universite du Quebec a Chicoutimi in Revue Organisations & territoires
- Vol. 34 (3) , 188-193
Open AccessSoutenir les micro-innovations comme moteur du changement en santé grâce à des approches participatives
Les systèmes de santé font face à des défis croissants qui nécessitent des innovations adaptées au terrain. En nous appuyant sur la place centrale des professionnels et des utilisateurs dans le Consolidated Framework for Implementation Research (CFIR; Breimaier et collab., 2015) pour instaurer et implanter le changement, nous mettons de l’avant le concept des micro-innovations. Ces initiatives locales peuvent transformer les pratiques organisationnelles. Nous présentons d’abord une micro-innovation locale qui a transformé les soins en fin de vie grâce à un protocole visant à protéger le patient et ses proches de la COVID-19 afin d’assurer du soutien émotionnel aux soins intensifs. Nous suggérons ensuite trois approches participatives pour faciliter l’émergence de micro-innovations : le design thinking, les hackathons et la cocréation avec les patients et proches-partenaires. Pour générer un réel impact, ces micro-innovations nécessitent un accompagnement organisationnel. En les valorisant, les systèmes de santé peuvent évoluer de manière plus agile, inclusive et durable.
- Open Access
- 9 November 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Artificial Intelligence Governance in Health Systems: A Systematic Review of Frameworks and an Integrative Model Proposal (Preprint)
BACKGROUND Robust and adaptive artificial intelligence (AI) governance frameworks are essential to ensure the responsible, sustainable and effective integration of AI-based technologies in health systems (HS). Over the past decade, numerous frameworks for governing AI in HS have been developed to foster accountability, support implementation and mitigate risks such as bias, compromised quality of care, data breaches and adverse financial impacts. However, current frameworks often fail to reflect the multidimensional and dynamic nature of AI governance in HS. OBJECTIVE This study had two objectives: (1) To review and synthesize existing AI governance frameworks for HS; and (2) To propose an Integrative AI Governance Model that identifies key components to guide AI-related policy, practice and research in HS. METHODS We conducted a systematic review of AI governance frameworks for HS published from November 2014 to July 2025. Sources included eight academic databases (PubMed, MEDLINE, Embase, ACM Digital Library, Web of Science, Scopus, Social Sciences Abstracts and PsycINFO), grey-literature databases, and the web portals of international organizations. Inclusion criteria covered peer-reviewed articles and reports proposing a framework, guideline, standard or position statement on the governance of AI in HS. We excluded abstracts, letters to the editor, commentaries, essays, viewpoints, conference proceedings, and articles in languages other than English, French, Spanish or Portuguese. Two reviewers independently selected papers, assessed framework quality using the Appraisal of Guidelines for Research and Evaluation for Health Systems (AGREE-HS), and extracted data. A thematic analysis was then conducted. RESULTS A total of 18 AI governance frameworks for HS were identified. Most were published between 2022 and 2024 and were rated as moderate or low quality. The frameworks targeted four levels: international (n = 3), national (n = 4), local (n = 3) and organizational (n = 8). The composition of actors within governance structures varied across levels. Six key governance processes in HS emerged as critical: (1) Needs and/or problem identification; (2) Data governance; (3) Risk assessment and management; (4) Validation and/or evaluation; (5) Maintenance and monitoring; and (6) Integration. Four pivotal relational mechanisms were identified: (1) Ethical principles and/or values; (2) Education and training; (3) Standards and regulations; and (4) Communication. Barriers and challenges included poor alignment across interconnected policy domains and governance levels, the substantial resources required for effective implementation, and the ongoing demands of continuous monitoring of AI-based technologies. CONCLUSIONS The findings highlight key elements of AI governance, including structures, processes and relational mechanisms, distributed across the international, national, local and organizational levels. The proposed Integrative AI Governance Model for HS aims to inform constructive policy and practice discussions on how to ensure the responsible, sustainable and effective integration of AI-based technologies into HS. CLINICALTRIAL The protocol for the systematic review has been registered on the Open Science Framework (OSF) and is available at: https://doi.org/10.17605/OSF.IO/MCBTS
- 9 November 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessArtificial Intelligence Governance in Health Systems: A Systematic Review of Frameworks and an Integrative Model Proposal (Preprint)
BACKGROUND Robust and adaptive artificial intelligence (AI) governance frameworks are essential to ensure the responsible, sustainable and effective integration of AI-based technologies in health systems (HS). Over the past decade, numerous frameworks for governing AI in HS have been developed to foster accountability, support implementation and mitigate risks such as bias, compromised quality of care, data breaches and adverse financial impacts. However, current frameworks often fail to reflect the multidimensional and dynamic nature of AI governance in HS. OBJECTIVE This study had two objectives: (1) To review and synthesize existing AI governance frameworks for HS; and (2) To propose an Integrative AI Governance Model that identifies key components to guide AI-related policy, practice and research in HS. METHODS We conducted a systematic review of AI governance frameworks for HS published from November 2014 to July 2025. Sources included eight academic databases (PubMed, MEDLINE, Embase, ACM Digital Library, Web of Science, Scopus, Social Sciences Abstracts and PsycINFO), grey-literature databases, and the web portals of international organizations. Inclusion criteria covered peer-reviewed articles and reports proposing a framework, guideline, standard or position statement on the governance of AI in HS. We excluded abstracts, letters to the editor, commentaries, essays, viewpoints, conference proceedings, and articles in languages other than English, French, Spanish or Portuguese. Two reviewers independently selected papers, assessed framework quality using the Appraisal of Guidelines for Research and Evaluation for Health Systems (AGREE-HS), and extracted data. A thematic analysis was then conducted. RESULTS A total of 18 AI governance frameworks for HS were identified. Most were published between 2022 and 2024 and were rated as moderate or low quality. The frameworks targeted four levels: international (n = 3), national (n = 4), local (n = 3) and organizational (n = 8). The composition of actors within governance structures varied across levels. Six key governance processes in HS emerged as critical: (1) Needs and/or problem identification; (2) Data governance; (3) Risk assessment and management; (4) Validation and/or evaluation; (5) Maintenance and monitoring; and (6) Integration. Four pivotal relational mechanisms were identified: (1) Ethical principles and/or values; (2) Education and training; (3) Standards and regulations; and (4) Communication. Barriers and challenges included poor alignment across interconnected policy domains and governance levels, the substantial resources required for effective implementation, and the ongoing demands of continuous monitoring of AI-based technologies. CONCLUSIONS The findings highlight key elements of AI governance, including structures, processes and relational mechanisms, distributed across the international, national, local and organizational levels. The proposed Integrative AI Governance Model for HS aims to inform constructive policy and practice discussions on how to ensure the responsible, sustainable and effective integration of AI-based technologies into HS. CLINICALTRIAL The protocol for the systematic review has been registered on the Open Science Framework (OSF) and is available at: https://doi.org/10.17605/OSF.IO/MCBTS
- Open Access
- 19 August 2025
- Published by BMJ in BMJ Leader
- Vol. 10 (3) , 255-260
Leveraging local knowledge for crisis management: a practice-based approach to managing uncertainty in healthcare during COVID-19
Background/aim: Crises like the COVID-19 pandemic are inherently uncertain, dynamic and generate broader consequences on organisations, challenging traditional crisis management approaches. Conventional approaches often neglect the mechanisms and processes frontline practitioners enact in their local practices to adapt effectively. This study explores how healthcare professionals (HPs) at a university hospital centre developed and mobilised local knowledge to rapidly respond to the evolving conditions of the COVID-19 pandemic. Methods: We conducted an interpretive single case study at a designated COVID-19 university hospital in Montreal, Canada. Over 6 months (April to September 2020), we collected data through 49 virtual interviews with healthcare practitioners, minutes from an operational crisis unit and organisational records such as protocols and clinical algorithms. Our analysis focused on identifying spaces and mechanisms that facilitated the creation, testing and translation of local knowledge across different clinical units, leading to rapid organisational adaptation. Results: The study reveals that frontline HPs enacted new mechanisms forming three types of spacesreflective, experimental and translationalthat bypassed existing organisational structures of knowledge development. These spaces enabled the rapid development and translation of local knowledge, fostering dynamic organisational responses to the evolving crisis. Conclusion: By highlighting the critical role of local knowledge and the processes supporting its integration, this research offers valuable insights into improving crisis management practices. It emphasises frontline practitioners improvised and flexible organising processes that enable a more global capacity to leverage local knowledge for the effective adaptation in unprecedented crisis situations.
- 19 August 2025
- Published by BMJ in BMJ Leader
- Vol. 10 (3) , 255-260
Open AccessLeveraging local knowledge for crisis management: a practice-based approach to managing uncertainty in healthcare during COVID-19
Background/aim: Crises like the COVID-19 pandemic are inherently uncertain, dynamic and generate broader consequences on organisations, challenging traditional crisis management approaches. Conventional approaches often neglect the mechanisms and processes frontline practitioners enact in their local practices to adapt effectively. This study explores how healthcare professionals (HPs) at a university hospital centre developed and mobilised local knowledge to rapidly respond to the evolving conditions of the COVID-19 pandemic. Methods: We conducted an interpretive single case study at a designated COVID-19 university hospital in Montreal, Canada. Over 6 months (April to September 2020), we collected data through 49 virtual interviews with healthcare practitioners, minutes from an operational crisis unit and organisational records such as protocols and clinical algorithms. Our analysis focused on identifying spaces and mechanisms that facilitated the creation, testing and translation of local knowledge across different clinical units, leading to rapid organisational adaptation. Results: The study reveals that frontline HPs enacted new mechanisms forming three types of spacesreflective, experimental and translationalthat bypassed existing organisational structures of knowledge development. These spaces enabled the rapid development and translation of local knowledge, fostering dynamic organisational responses to the evolving crisis. Conclusion: By highlighting the critical role of local knowledge and the processes supporting its integration, this research offers valuable insights into improving crisis management practices. It emphasises frontline practitioners improvised and flexible organising processes that enable a more global capacity to leverage local knowledge for the effective adaptation in unprecedented crisis situations.
- Open Access
- 21 October 2024
- Published by Maad Rayan Publishing Company in International Journal of Health Policy and Management
- Vol. 13 (1) , 1-14
To What Extent Can Digital Health Technologies Comply With the Principles of Responsible Innovation? Practice-and Policy-Oriented Research Insights Regarding an Organisational and Systemic Issue
Background: Digital health technologies (DHTs) have expanded exponentially since the COVID-19 crisis and have prompted questions about their impact across all levels of health systems. Because health organisations and systems play a central role in the success or failure of the transition to more equitable and sustainable societies, the concept of Responsible Innovation in Health (RIH), focused on aligning the processes and outcomes of innovation with societal values, is gaining interest in research, policy, and practice. This study aims to explore enablers and constraints to the development, procurement and/or utilisation of responsible DHTs in health organisations. Methods: Semi-structured interviews were conducted with 29 stakeholders concerned with the development, procurement, and/or utilisation of DHTs in a large Canadian academic health centre. Data were thematically analysed through a mixed deductive-inductive process using the RIH framework. Results: Our findings highlight that the consideration of RIH principles in the development, procurement, and/or utilisation of DHTs depends mainly on organisational and systemic factors and conditions, namely: (1) the presence of an organisational culture that promotes RIH in its innovation-related practices and processes; (2) availability of material and financial resources as well as expertise in certain fields (eg, environmental sustainability); (3) the evolution of health technology assessment (HTA) practices to include other dimensions beyond effectiveness, safety, and costs; (4) the scope of the regulatory and legal frameworks that govern the approval and use of DHTs; and (5) the role of the market (eg, venture capital) in the design of federal and provincial innovation policies. Conclusion: This study provides insights on practice, policy, and political issues that health organisations may face in the development, procurement, and/or utilisation of responsible DHTs. It can help scholars, practitioners, decision-makers, and industry to create the conditions for a better integration of RIH principles into health organisations and systems.
- 21 October 2024
- Published by Maad Rayan Publishing Company in International Journal of Health Policy and Management
- Vol. 13 (1) , 1-14
Open AccessTo What Extent Can Digital Health Technologies Comply With the Principles of Responsible Innovation? Practice-and Policy-Oriented Research Insights Regarding an Organisational and Systemic Issue
Background: Digital health technologies (DHTs) have expanded exponentially since the COVID-19 crisis and have prompted questions about their impact across all levels of health systems. Because health organisations and systems play a central role in the success or failure of the transition to more equitable and sustainable societies, the concept of Responsible Innovation in Health (RIH), focused on aligning the processes and outcomes of innovation with societal values, is gaining interest in research, policy, and practice. This study aims to explore enablers and constraints to the development, procurement and/or utilisation of responsible DHTs in health organisations. Methods: Semi-structured interviews were conducted with 29 stakeholders concerned with the development, procurement, and/or utilisation of DHTs in a large Canadian academic health centre. Data were thematically analysed through a mixed deductive-inductive process using the RIH framework. Results: Our findings highlight that the consideration of RIH principles in the development, procurement, and/or utilisation of DHTs depends mainly on organisational and systemic factors and conditions, namely: (1) the presence of an organisational culture that promotes RIH in its innovation-related practices and processes; (2) availability of material and financial resources as well as expertise in certain fields (eg, environmental sustainability); (3) the evolution of health technology assessment (HTA) practices to include other dimensions beyond effectiveness, safety, and costs; (4) the scope of the regulatory and legal frameworks that govern the approval and use of DHTs; and (5) the role of the market (eg, venture capital) in the design of federal and provincial innovation policies. Conclusion: This study provides insights on practice, policy, and political issues that health organisations may face in the development, procurement, and/or utilisation of responsible DHTs. It can help scholars, practitioners, decision-makers, and industry to create the conditions for a better integration of RIH principles into health organisations and systems.
- Open Access
- 22 March 2024
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 13 (1) , e54440
Telehealth-Delivered Program and Accompanying Patients to Enhance the Clinical Condition of Patients Throughout a Liver Transplant: Protocol for a Mixed Methods Study
Background: Liver transplantation (LT) is indicated in patients with severe acute or chronic liver failure for which no other therapy is available. With the increasing number of LTs in recent years, liver centers worldwide must manage their patients according to their clinical situation and the expected waiting time for transplantation. The LT clinic at the Centre hospitalier de l’Université de Montréal (CHUM) is developing a new health care model across the entire continuum of pre-, peri-, and posttransplant care that features patient monitoring by an interdisciplinary team, including an accompanying patient; a digital platform to host a clinical plan; a learning program; and data collection from connected objects. Objective: This study aims to (1) evaluate the outcomes following the implementation of a patient platform with connected devices and an accompanying patient, (2) identify implementation barriers and facilitators, (3) describe service outcomes in terms of health outcomes and the rates and nature of contact with the accompanying patient, (4) describe patient outcomes, and (5) assess the intervention’s cost-effectiveness. Methods: Six types of participants will be included in the study: (1) patients who received transplants and reached 1 year after transplantation before September 2023 (historical cohort or control group), (2) patients who will receive an LT between December 2023 and November 2024 (prospective cohort/intervention group), (3) relatives of those patients, (4) accompanying patients who have received an LT and are interested in supporting patients who will receive an LT, (5) health care professionals, and (6) decision makers. To describe the study sample and collect data to achieve all the objectives, a series of validated questionnaires, accompanying patient logbooks, transcripts of interviews and focus groups, and clinical indicators will be collected throughout the study. Results: In total, 5 (steering, education, clinical-technological, nurse prescription, and accompanying patient) working committees have been established for the study. Recruitment of patients is expected to start in November 2023. All questionnaires and technological platforms have been prepared, and the clinicians, stakeholders, and accompanying patient personnel have been recruited. Conclusions: The implementation of this model in the trajectory of LT recipients at the CHUM may allow for better monitoring and health of patients undergoing transplantation, ultimately reducing the average length of hospital stay and promoting better use of medical resources. In the event of positive results, this model could be transposed to all transplant units at the CHUM and across Quebec (potentially affecting 888 patients per year) but could also be applied more widely to the monitoring of patients with other chronic diseases. The lessons learned from this project will be shared with decision makers and will serve as a model for other initiatives involving accompanying patients, connected objects, or digital platforms. International Registered Report Identifier (IRRID): PRR1-10.2196/54440
- 22 March 2024
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 13 (1) , e54440
Open AccessTelehealth-Delivered Program and Accompanying Patients to Enhance the Clinical Condition of Patients Throughout a Liver Transplant: Protocol for a Mixed Methods Study
Background: Liver transplantation (LT) is indicated in patients with severe acute or chronic liver failure for which no other therapy is available. With the increasing number of LTs in recent years, liver centers worldwide must manage their patients according to their clinical situation and the expected waiting time for transplantation. The LT clinic at the Centre hospitalier de l’Université de Montréal (CHUM) is developing a new health care model across the entire continuum of pre-, peri-, and posttransplant care that features patient monitoring by an interdisciplinary team, including an accompanying patient; a digital platform to host a clinical plan; a learning program; and data collection from connected objects. Objective: This study aims to (1) evaluate the outcomes following the implementation of a patient platform with connected devices and an accompanying patient, (2) identify implementation barriers and facilitators, (3) describe service outcomes in terms of health outcomes and the rates and nature of contact with the accompanying patient, (4) describe patient outcomes, and (5) assess the intervention’s cost-effectiveness. Methods: Six types of participants will be included in the study: (1) patients who received transplants and reached 1 year after transplantation before September 2023 (historical cohort or control group), (2) patients who will receive an LT between December 2023 and November 2024 (prospective cohort/intervention group), (3) relatives of those patients, (4) accompanying patients who have received an LT and are interested in supporting patients who will receive an LT, (5) health care professionals, and (6) decision makers. To describe the study sample and collect data to achieve all the objectives, a series of validated questionnaires, accompanying patient logbooks, transcripts of interviews and focus groups, and clinical indicators will be collected throughout the study. Results: In total, 5 (steering, education, clinical-technological, nurse prescription, and accompanying patient) working committees have been established for the study. Recruitment of patients is expected to start in November 2023. All questionnaires and technological platforms have been prepared, and the clinicians, stakeholders, and accompanying patient personnel have been recruited. Conclusions: The implementation of this model in the trajectory of LT recipients at the CHUM may allow for better monitoring and health of patients undergoing transplantation, ultimately reducing the average length of hospital stay and promoting better use of medical resources. In the event of positive results, this model could be transposed to all transplant units at the CHUM and across Quebec (potentially affecting 888 patients per year) but could also be applied more widely to the monitoring of patients with other chronic diseases. The lessons learned from this project will be shared with decision makers and will serve as a model for other initiatives involving accompanying patients, connected objects, or digital platforms. International Registered Report Identifier (IRRID): PRR1-10.2196/54440
- Open Access
- 16 November 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Telehealth-Delivered Program and Accompanying Patients to Enhance the Clinical Condition of Patients Throughout a Liver Transplant: Protocol for a Mixed Methods Study (Preprint)
BACKGROUND Liver transplantation (LT) is indicated in patients with severe acute or chronic liver failure for which no other therapy is available. With the increasing number of LTs in recent years, liver centers worldwide must manage their patients according to their clinical situation and the expected waiting time for transplantation. The LT clinic at the Centre hospitalier de l’Université de Montréal (CHUM) is developing a new health care model across the entire continuum of pre-, peri-, and posttransplant care that features patient monitoring by an interdisciplinary team, including an accompanying patient; a digital platform to host a clinical plan; a learning program; and data collection from connected objects. OBJECTIVE This study aims to (1) evaluate the outcomes following the implementation of a patient platform with connected devices and an accompanying patient, (2) identify implementation barriers and facilitators, (3) describe service outcomes in terms of health outcomes and the rates and nature of contact with the accompanying patient, (4) describe patient outcomes, and (5) assess the intervention’s cost-effectiveness. METHODS Six types of participants will be included in the study: (1) patients who received transplants and reached 1 year after transplantation before September 2023 (historical cohort or control group), (2) patients who will receive an LT between December 2023 and November 2024 (prospective cohort/intervention group), (3) relatives of those patients, (4) accompanying patients who have received an LT and are interested in supporting patients who will receive an LT, (5) health care professionals, and (6) decision makers. To describe the study sample and collect data to achieve all the objectives, a series of validated questionnaires, accompanying patient logbooks, transcripts of interviews and focus groups, and clinical indicators will be collected throughout the study. RESULTS In total, 5 (steering, education, clinical-technological, nurse prescription, and accompanying patient) working committees have been established for the study. Recruitment of patients is expected to start in November 2023. All questionnaires and technological platforms have been prepared, and the clinicians, stakeholders, and accompanying patient personnel have been recruited. CONCLUSIONS The implementation of this model in the trajectory of LT recipients at the CHUM may allow for better monitoring and health of patients undergoing transplantation, ultimately reducing the average length of hospital stay and promoting better use of medical resources. In the event of positive results, this model could be transposed to all transplant units at the CHUM and across Quebec (potentially affecting 888 patients per year) but could also be applied more widely to the monitoring of patients with other chronic diseases. The lessons learned from this project will be shared with decision makers and will serve as a model for other initiatives involving accompanying patients, connected objects, or digital platforms. INTERNATIONAL REGISTERED REPORT PRR1-10.2196/54440
- 16 November 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessTelehealth-Delivered Program and Accompanying Patients to Enhance the Clinical Condition of Patients Throughout a Liver Transplant: Protocol for a Mixed Methods Study (Preprint)
BACKGROUND Liver transplantation (LT) is indicated in patients with severe acute or chronic liver failure for which no other therapy is available. With the increasing number of LTs in recent years, liver centers worldwide must manage their patients according to their clinical situation and the expected waiting time for transplantation. The LT clinic at the Centre hospitalier de l’Université de Montréal (CHUM) is developing a new health care model across the entire continuum of pre-, peri-, and posttransplant care that features patient monitoring by an interdisciplinary team, including an accompanying patient; a digital platform to host a clinical plan; a learning program; and data collection from connected objects. OBJECTIVE This study aims to (1) evaluate the outcomes following the implementation of a patient platform with connected devices and an accompanying patient, (2) identify implementation barriers and facilitators, (3) describe service outcomes in terms of health outcomes and the rates and nature of contact with the accompanying patient, (4) describe patient outcomes, and (5) assess the intervention’s cost-effectiveness. METHODS Six types of participants will be included in the study: (1) patients who received transplants and reached 1 year after transplantation before September 2023 (historical cohort or control group), (2) patients who will receive an LT between December 2023 and November 2024 (prospective cohort/intervention group), (3) relatives of those patients, (4) accompanying patients who have received an LT and are interested in supporting patients who will receive an LT, (5) health care professionals, and (6) decision makers. To describe the study sample and collect data to achieve all the objectives, a series of validated questionnaires, accompanying patient logbooks, transcripts of interviews and focus groups, and clinical indicators will be collected throughout the study. RESULTS In total, 5 (steering, education, clinical-technological, nurse prescription, and accompanying patient) working committees have been established for the study. Recruitment of patients is expected to start in November 2023. All questionnaires and technological platforms have been prepared, and the clinicians, stakeholders, and accompanying patient personnel have been recruited. CONCLUSIONS The implementation of this model in the trajectory of LT recipients at the CHUM may allow for better monitoring and health of patients undergoing transplantation, ultimately reducing the average length of hospital stay and promoting better use of medical resources. In the event of positive results, this model could be transposed to all transplant units at the CHUM and across Quebec (potentially affecting 888 patients per year) but could also be applied more widely to the monitoring of patients with other chronic diseases. The lessons learned from this project will be shared with decision makers and will serve as a model for other initiatives involving accompanying patients, connected objects, or digital platforms. INTERNATIONAL REGISTERED REPORT PRR1-10.2196/54440
- Open Access
- 28 August 2023
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 25 (1) , e48496
A Comprehensive, Valid, and Reliable Tool to Assess the Degree of Responsibility of Digital Health Solutions That Operate With or Without Artificial Intelligence: 3-Phase Mixed Methods Study
Background: Clinicians’ scope of responsibilities is being steadily transformed by digital health solutions that operate with or without artificial intelligence (DAI solutions). Most tools developed to foster ethical practices lack rigor and do not concurrently capture the health, social, economic, and environmental issues that such solutions raise. Objective: To support clinical leadership in this field, we aimed to develop a comprehensive, valid, and reliable tool that measures the responsibility of DAI solutions by adapting the multidimensional and already validated Responsible Innovation in Health Tool. Methods: We conducted a 3-phase mixed methods study. Relying on a scoping review of available tools, phase 1 (concept mapping) led to a preliminary version of the Responsible DAI solutions Assessment Tool. In phase 2, an international 2-round e-Delphi expert panel rated on a 5-level scale the importance, clarity, and appropriateness of the tool’s components. In phase 3, a total of 2 raters independently applied the revised tool to a sample of DAI solutions (n=25), interrater reliability was measured, and final minor changes were made to the tool. Results: The mapping process identified a comprehensive set of responsibility premises, screening criteria, and assessment attributes specific to DAI solutions. e-Delphi experts critically assessed these new components and provided comments to increase content validity (n=293), and after round 2, consensus was reached on 85% (22/26) of the items surveyed. Interrater agreement was substantial for a subcriterion and almost perfect for all other criteria and assessment attributes. Conclusions: The Responsible DAI solutions Assessment Tool offers a comprehensive, valid, and reliable means of assessing the degree of responsibility of DAI solutions in health. As regulation remains limited, this forward-looking tool has the potential to change practice toward more equitable as well as economically and environmentally sustainable digital health care.
- 28 August 2023
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 25 (1) , e48496
Open AccessA Comprehensive, Valid, and Reliable Tool to Assess the Degree of Responsibility of Digital Health Solutions That Operate With or Without Artificial Intelligence: 3-Phase Mixed Methods Study
Background: Clinicians’ scope of responsibilities is being steadily transformed by digital health solutions that operate with or without artificial intelligence (DAI solutions). Most tools developed to foster ethical practices lack rigor and do not concurrently capture the health, social, economic, and environmental issues that such solutions raise. Objective: To support clinical leadership in this field, we aimed to develop a comprehensive, valid, and reliable tool that measures the responsibility of DAI solutions by adapting the multidimensional and already validated Responsible Innovation in Health Tool. Methods: We conducted a 3-phase mixed methods study. Relying on a scoping review of available tools, phase 1 (concept mapping) led to a preliminary version of the Responsible DAI solutions Assessment Tool. In phase 2, an international 2-round e-Delphi expert panel rated on a 5-level scale the importance, clarity, and appropriateness of the tool’s components. In phase 3, a total of 2 raters independently applied the revised tool to a sample of DAI solutions (n=25), interrater reliability was measured, and final minor changes were made to the tool. Results: The mapping process identified a comprehensive set of responsibility premises, screening criteria, and assessment attributes specific to DAI solutions. e-Delphi experts critically assessed these new components and provided comments to increase content validity (n=293), and after round 2, consensus was reached on 85% (22/26) of the items surveyed. Interrater agreement was substantial for a subcriterion and almost perfect for all other criteria and assessment attributes. Conclusions: The Responsible DAI solutions Assessment Tool offers a comprehensive, valid, and reliable means of assessing the degree of responsibility of DAI solutions in health. As regulation remains limited, this forward-looking tool has the potential to change practice toward more equitable as well as economically and environmentally sustainable digital health care.
- Open Access
- 25 April 2023
- Published by JMIR Publications Inc. in JMIR Preprints
A Comprehensive, Valid, and Reliable Tool to Assess the Degree of Responsibility of Digital Health Solutions That Operate With or Without Artificial Intelligence: 3-Phase Mixed Methods Study (Preprint)
BACKGROUND Clinicians’ scope of responsibilities is being steadily transformed by digital health solutions that operate with or without artificial intelligence (DAI solutions). Most tools developed to foster ethical practices lack rigor and do not concurrently capture the health, social, economic, and environmental issues that such solutions raise. OBJECTIVE To support clinical leadership in this field, we aimed to develop a comprehensive, valid, and reliable tool that measures the responsibility of DAI solutions by adapting the multidimensional and already validated Responsible Innovation in Health Tool. METHODS We conducted a 3-phase mixed methods study. Relying on a scoping review of available tools, phase 1 (concept mapping) led to a preliminary version of the Responsible DAI solutions Assessment Tool. In phase 2, an international 2-round e-Delphi expert panel rated on a 5-level scale the importance, clarity, and appropriateness of the tool’s components. In phase 3, a total of 2 raters independently applied the revised tool to a sample of DAI solutions (n=25), interrater reliability was measured, and final minor changes were made to the tool. RESULTS The mapping process identified a comprehensive set of responsibility premises, screening criteria, and assessment attributes specific to DAI solutions. e-Delphi experts critically assessed these new components and provided comments to increase content validity (n=293), and after round 2, consensus was reached on 85% (22/26) of the items surveyed. Interrater agreement was substantial for a subcriterion and almost perfect for all other criteria and assessment attributes. CONCLUSIONS The Responsible DAI solutions Assessment Tool offers a comprehensive, valid, and reliable means of assessing the degree of responsibility of DAI solutions in health. As regulation remains limited, this forward-looking tool has the potential to change practice toward more equitable as well as economically and environmentally sustainable digital health care.
- 25 April 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessA Comprehensive, Valid, and Reliable Tool to Assess the Degree of Responsibility of Digital Health Solutions That Operate With or Without Artificial Intelligence: 3-Phase Mixed Methods Study (Preprint)
BACKGROUND Clinicians’ scope of responsibilities is being steadily transformed by digital health solutions that operate with or without artificial intelligence (DAI solutions). Most tools developed to foster ethical practices lack rigor and do not concurrently capture the health, social, economic, and environmental issues that such solutions raise. OBJECTIVE To support clinical leadership in this field, we aimed to develop a comprehensive, valid, and reliable tool that measures the responsibility of DAI solutions by adapting the multidimensional and already validated Responsible Innovation in Health Tool. METHODS We conducted a 3-phase mixed methods study. Relying on a scoping review of available tools, phase 1 (concept mapping) led to a preliminary version of the Responsible DAI solutions Assessment Tool. In phase 2, an international 2-round e-Delphi expert panel rated on a 5-level scale the importance, clarity, and appropriateness of the tool’s components. In phase 3, a total of 2 raters independently applied the revised tool to a sample of DAI solutions (n=25), interrater reliability was measured, and final minor changes were made to the tool. RESULTS The mapping process identified a comprehensive set of responsibility premises, screening criteria, and assessment attributes specific to DAI solutions. e-Delphi experts critically assessed these new components and provided comments to increase content validity (n=293), and after round 2, consensus was reached on 85% (22/26) of the items surveyed. Interrater agreement was substantial for a subcriterion and almost perfect for all other criteria and assessment attributes. CONCLUSIONS The Responsible DAI solutions Assessment Tool offers a comprehensive, valid, and reliable means of assessing the degree of responsibility of DAI solutions in health. As regulation remains limited, this forward-looking tool has the potential to change practice toward more equitable as well as economically and environmentally sustainable digital health care.
- 12 August 2022
- Published by SAGE Publications in Healthcare Management Forum
- Vol. 35 (6) , 344-348
Reconnecting health through innovation
Learning health systems identify appropriate data to improve their performance and population health. The pandemic has shown that a proper response depends on using data from patients' needs, scientific research, hospital capacity, digital innovations, and stakeholder knowledge. Academic health centres play a role in data collection, information synthesis, and decision making supported by digital innovations. The results obtained by an academic centre and network in Quebec have demonstrated the value of integrating these elements during the pandemic and beyond.
- 12 August 2022
- Published by SAGE Publications in Healthcare Management Forum
- Vol. 35 (6) , 344-348
Reconnecting health through innovation
Learning health systems identify appropriate data to improve their performance and population health. The pandemic has shown that a proper response depends on using data from patients' needs, scientific research, hospital capacity, digital innovations, and stakeholder knowledge. Academic health centres play a role in data collection, information synthesis, and decision making supported by digital innovations. The results obtained by an academic centre and network in Quebec have demonstrated the value of integrating these elements during the pandemic and beyond.